1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL COAGULATION TESTING MARKET BY TEST TYPE
5.1. Introduction
5.2. Prothrombin Time Testing
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Fibrinogen Testing
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
5.4. Activated Clotting Time Testing
5.4.1. Market Opportunities and Trends
5.4.2. Growth Prospects
5.4.3. Geographic Lucrativeness
5.5. Platelet Function Tests
5.5.1. Market Opportunities and Trends
5.5.2. Growth Prospects
5.5.3. Geographic Lucrativeness
5.6. Other
5.6.1. Market Opportunities and Trends
5.6.2. Growth Prospects
5.6.3. Geographic Lucrativeness
6. GLOBAL COAGULATION TESTING MARKET BY END USERS
6.1. Introduction
6.2. Hospitals and Clinics
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Diagnostic Centres
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
6.4. Ambulatory Care Centres
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
6.4.3. Geographic Lucrativeness
7. GLOBAL COAGULATION TESTING MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. By Test Type
7.2.2. By End Users
7.2.3. By Country
7.2.3.1. United States
7.2.3.1.1. Market Opportunities and Trends
7.2.3.1.2. Growth Prospects
7.2.3.2. Canada
7.2.3.2.1. Market Opportunities and Trends
7.2.3.2.2. Growth Prospects
7.2.3.3. Mexico
7.2.3.3.1. Market Opportunities and Trends
7.2.3.3.2. Growth Prospects
7.3. South America
7.3.1. By Test Type
7.3.2. By End Users
7.3.3. By Country
7.3.3.1. Brazil
7.3.3.1.1. Market Opportunities and Trends
7.3.3.1.2. Growth Prospects
7.3.3.2. Argentina
7.3.3.2.1. Market Opportunities and Trends
7.3.3.2.2. Growth Prospects
7.3.3.3. Others
7.3.3.3.1. Market Opportunities and Trends
7.3.3.3.2. Growth Prospects
7.4. Europe
7.4.1. By Test Type
7.4.2. By End Users
7.4.3. By Country
7.4.3.1. UK
7.4.3.1.1. Market Opportunities and Trends
7.4.3.1.2. Growth Prospects
7.4.3.2. Germany
7.4.3.2.1. Market Opportunities and Trends
7.4.3.2.2. Growth Prospects
7.4.3.3. France
7.4.3.3.1. Market Opportunities and Trends
7.4.3.3.2. Growth Prospects
7.4.3.4. Others
7.4.3.4.1. Market Opportunities and Trends
7.4.3.4.2. Growth Prospects
7.5. Middle East and Africa
7.5.1. By Test Type
7.5.2. By End Users
7.5.3. By Country
7.5.3.1. Saudi Arabia
7.5.3.1.1. Market Opportunities and Trends
7.5.3.1.2. Growth Prospects
7.5.3.2. UAE
7.5.3.2.1. Market Opportunities and Trends
7.5.3.2.2. Growth Prospects
7.5.3.3. Israel
7.5.3.3.1. Market Opportunities and Trends
7.5.3.3.2. Growth Prospects
7.5.3.4. Others
7.5.3.4.1. Market Opportunities and Trends
7.5.3.4.2. Growth Prospects
7.6. Asia Pacific
7.6.1. By Test Type
7.6.2. By End Users
7.6.3. By Country
7.6.3.1. China
7.6.3.1.1. Market Opportunities and Trends
7.6.3.1.2. Growth Prospects
7.6.3.2. India
7.6.3.2.1. Market Opportunities and Trends
7.6.3.2.2. Growth Prospects
7.6.3.3. South Korea
7.6.3.3.1. Market Opportunities and Trends
7.6.3.3.2. Growth Prospects
7.6.3.4. Taiwan
7.6.3.4.1. Market Opportunities and Trends
7.6.3.4.2. Growth Prospects
7.6.3.5. Thailand
7.6.3.5.1. Market Opportunities and Trends
7.6.3.5.2. Growth Prospects
7.6.3.6. Indonesia
7.6.3.6.1. Market Opportunities and Trends
7.6.3.6.2. Growth Prospects
7.6.3.7. Japan
7.6.3.7.1. Market Opportunities and Trends
7.6.3.7.2. Growth Prospects
7.6.3.8. Others
7.6.3.8.1. Market Opportunities and Trends
7.6.3.8.2. Growth Prospects
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Abbott
9.2. Diagnostica Stago, S.A.S.
9.3. F. Hoffmann-La Roche Ltd
9.4. Thermo Fisher Scientific
9.5. Enzyme Research Laboratories Ltd
9.6. Sekisui Medical Co., Ltd.
9.7. Stago Group
9.8. Coagulation Sciences LLC
9.9. RUSNANO Group
9.10. Universal Biosensors